Overview
Joseph Moore is a Hematologist Oncology provider in Durham, North Carolina. Dr. Moore is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome.
His clinical research consists of co-authoring 52 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Blood Cancer Center
As a physician and scientist, my ultimate goal is to translate research findings from bench to beside to improve patient care. I focus my research and clinical work on treating blood and bone marrow cancers. Most of the patients in my clinic are blood and bone marrow transplant patients and patients with plasma cell diseases such as multiple myeloma, amyloidosis, POEMS syndrome, and Waldenstrom's macroglobulinemia. The research interests in my lab are on the development of new approaches to enhance hematopoietic stem cell engraftment and reconstitution following blood and bone marrow transplant. Dr. Kang is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Schnitzler Syndrome, Bone Marrow Aspiration, and Bone Graft.
University Of North Carolina At Chapel Hill
Eben Lichtman is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Lichtman is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Lichtman is currently accepting new patients.
Duke Blood Cancer Center
Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Moore isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Moore isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Moore isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Moore isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Moore isAdvanced. Learn about Adrenal Cancer.
- B-Cell LymphomaDr. Moore isAdvanced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid Leukemia
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaDr. Moore isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Promyelocytic LeukemiaDr. Moore isExperienced. Learn about Acute Promyelocytic Leukemia.
- Angioimmunoblastic T-cell LymphomaDr. Moore isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Carcinoid SyndromeDr. Moore isExperienced. Learn about Carcinoid Syndrome.
- Childhood Iron Deficiency AnemiaDr. Moore isExperienced. Learn about Childhood Iron Deficiency Anemia.

